News
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
Vinay Prasad, named to lead the FDA agency tasked with regulating vaccines and gene therapy, has made controversial comments ...
The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.
A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...
Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...
(Gray News) - A combination shot for flu and COVID-19 using messenger RNA-generated antibodies in a study, but U.S.
The UCSF professor and frequent YouTube poster has criticized COVID-19 vaccine mandates as well as the accelerated approval ...
7hOpinion
MedPage Today on MSNVinay Prasad Speaks to CBER Staff: Which Prasad Showed Up?The question on many minds among FDA rank-and-file in attendance was: Which Prasad would show up? The 2010s Prasad -- a ...
Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...
CBS Boston on MSN1h
Moderna claims to have combined flu and COVID-19 vaccinesThe Cambridge-based company says the vaccine is at least as good as getting both vaccines separately, it will seek FDA ...
Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results